OR WAIT 15 SECS
Moxatag is the name of a new once-daily amoxicillin product for pharyngitis and tonsillitis following strep throat
MiddleBrook Pharmaceuticals' Moxatag (amoxicillin extended-release) Tablets 775 mg have been approved to treat adults and children 12 and older with pharyngitis and/or tonsillitis secondary to strep throat. The Germantown, Md., firm claims that its product is the first once-daily amoxicillin product approved in this country. Its convenient dosing should ensure better drug compliance.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.